Ivy Natal Company
.jpg)
Ivy Natal develops a process to create human egg cells from skin samples as a treatment for most cases of infertility.
Last Funding Type:
Seed
Funding Status:
Seed
Headquarters:
San Francisco, California, United States
Founded Date:
01-01-2020
Last Funding Date:
2020-04-14
Total Funding:
$250,000
Employee Number:
1-10
Investors Number:
2
Industry:
Reproductive Health & Contraception